IQ U.S. Mid Cap R&D Leaders ETF
MRND
MRND was delisted on the 12th of December, 2023.
2 hedge funds and large institutions have $3.74M invested in IQ U.S. Mid Cap R&D Leaders ETF in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
3% more capital invested
Capital invested by funds: $3.61M → $3.74M (+$126K)
0% more funds holding
Funds holding: 2 → 2 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$241 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NYLIM
1
New York Life Investment Management
New York
| $3.73M | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $9.53K | -$241 | -12 | -2% |
|
MRND Hedge Fund Activity: Q4 2022 in Review
2 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in IQ U.S. Mid Cap R&D Leaders ETF (MRND) for Q4 2022, worth a combined $3.74M — up 3.5% from $3.61M a quarter earlier.
Fund positioning in MRND was balanced in Q4 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $241.
- 2 institutional investors held IQ U.S. Mid Cap R&D Leaders ETF (MRND) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $3.74M of IQ U.S. Mid Cap R&D Leaders ETF stock for Q4 2022, up 3.5% quarter-over-quarter.
- 0 funds opened new IQ U.S. Mid Cap R&D Leaders ETF positions in Q4 2022 and 0 closed out.
- The largest IQ U.S. Mid Cap R&D Leaders ETF seller in Q4 2022 was UBS Group, an estimated $241 sold.
Based on aggregated 13F filings for Q4 2022.